results of placebo controlled study of tasquinimod in men with castrate resistant prostate cancer
Published 9 years ago • 102 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
19:51
metastatic prostate cancer - interpreting negative trial results
-
11:51
expert video report on castration sensitive and resistant prostate cancer - 2021 asco annual meeting
-
39:15
aua: sequencing of agents and combination therapy in castrate resistant prostate cancer
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
8:14
case study: treating asymptomatic metastatic castration-resistant prostate cancer
-
4:46
quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
-
12:36
chemotherapy for castrate resistant prostate cancer
-
7:15
optimizing biomarker testing for patients with metastatic prostate cancer
-
30:30
exploring the evolution in metastatic hormone sensitive & castration resistant prostate cancer
-
16:35
overall survival with sipuleucel-t in patients treated for advanced prostate cancer
-
18:21
decisional tools to determine need for biopsy and re-biopsy in men with elevated psas
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
8:15
introduction and overview of castration-resistant prostate cancer treatment challenges
-
6:42
immunotherapy in castration-resistant prostate cancer, part i
-
4:05
presto study
-
3:06
treatment intensification in metastatic castration-sensitive prostate cancer
-
1:52:45
aua guidelines on advanced/metastatic/castration resistant prostate cancer webcast (2021)
-
3:48
what is the 4kscore™ test by opko health?
-
3:12
is the triplet regimen standard of care for metastatic castrate-sensitive prostate cancer?